Skip to main content
Tech.euFundingExplorerBeta

AntalGenics

Neuropharmaceutical that eliminates the chronic itching of Psoriasis

Total raised
€808k
€808,000
Funding rounds
1
Investors
4
distinct backers
Active since
2022-02
latest 2022-02

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood12
base rate 34% for Crowdfunding
  • Dormant (no round in 3+ cohort gaps)
  • Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds
DateStageAmountInvestors
2022-02-16Crowdfunding€808kAntonio Ferrer,Antonio Parente,Capital Cell,InvereadyView deal →

Similar companies

same sector or country